Lower riskDrug recall · FDA · Published December 27, 2024
Eugia Progesterone Injection Recall: Glass Particles in Vials
Eugia recalls progesterone injections with glass particles found in vials. This may cause injury during medical use. Affected vials were manufactured in India with specific batch numbers.
“Eugia Progesterone Injection Recall: Glass Particles in Vials.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32342-eugia-progesterone-injection-recall-glass-particles-in-vials. Based on FDA recall #D-0186-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0186-2025%22&limit=1).
Eugia US LLC recalled Progesterone Injection USP, 500mg per 10 mL vials nationwide due to the presence of particulate matter, according to the FDA. The Food and Drug Administration announced the Class II voluntary recall on December 27, 2024.
How to tell if you have it
Brand: Eugia
Product: Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only
NDC # 55150-306-10
Batch # 1PR24010
Expiry: 02/28/2027
Quantity: 17,300 units
The hazard
The recall addresses a market complaint regarding the presence of a glass piece in the vial. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Eugia US LLC has conducted 14 other recalls since December 28, 2022. Recent brand recalls include a May 18, 2026 Lidocaine injection recall for label scanning issues and a May 29, 2025 Gentamicin Injection recall due to stability failure. Other recent recalls of similar products include Fresenius Kabi Tyenne Injection Recall (August 10, 2026) and GE Healthcare Omnipaque Injection Recalls (March 24, 2026).
How to tell if you have this one
Check for vials labeled 'Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only'. They were manufactured in India with batch number 1PR24010 and expire 02/28/2027.
Brand
Eugia
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Vial Label
Look for the specific product name and batch number on the vial label.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Distributed Nationwide in the USA.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 19 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The recall states glass particles were found in the vial, but no injuries were reported. The product is not safe for use until the recall is addressed.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0186-2025 (December 27, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0186-2025 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.